Malcolm Ranson
Impact in
- Oncology top 0.2%
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 81
- Lung Cancer Research Studies 20
- Cancer Treatment and Pharmacology 18
- HER2/EGFR in Cancer Research 14
- Colorectal Cancer Treatments and Studies 13
-
- Cancer therapeutics and mechanisms 20
- Cell death mechanisms and regulation 13
- Co-authors
- Caroline Dive (38 shared papers)Fiona Blackhall (15 shared papers)Andrew Hughes (17 shared papers)Alastair Greystoke (24 shared papers)Tim Ward (14 shared papers)Helen Swaisland (12 shared papers)Sarah Danson (18 shared papers)Matthew Krebs (9 shared papers)
- Journals
- Journal of Clinical Oncology (38 papers)British Journal of Cancer (21 papers)Annals of Oncology (14 papers)European Journal of Cancer (11 papers)Clinical Cancer Research (6 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Malcolm Ranson
176 papers receiving 11.1k citations
Malcolm Ranson's Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 5.5k
- Cancer Research 1.9k
- Pulmonary and Respiratory Medicine 4.1k
- Molecular Biology 3.7k
- Biomaterials 645
Countries citing papers authored by Malcolm Ranson
This map shows the geographic impact of Malcolm Ranson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Ranson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Ranson more than expected).
Fields of papers citing papers by Malcolm Ranson
This network shows the impact of papers produced by Malcolm Ranson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Ranson. The network helps show where Malcolm Ranson may publish in the future.
Co-authors
The 25 scholars most cited alongside Malcolm Ranson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer Hit paper breakdown → | 2015 | 1600 |
| 2 | Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer Hit paper breakdown → | 2011 | 716 |
| 3 | Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types Hit paper breakdown → | 2002 | 683 |
| 4 | ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial Hit paper breakdown → | 2002 | 646 |
| 5 | 2011 | 376 | |
| 6 | 2011 | 343 | |
| 7 | 2004 | 300 | |
| 8 | 1997 | 244 | |
| 9 | 2000 | 222 | |
| 10 | 2010 | 214 | |
| 11 | 2007 | 213 | |
| 12 | 2009 | 194 | |
| 13 | 2009 | 191 | |
| 14 | 2001 | 175 | |
| 15 | 2010 | 165 | |
| 16 | 2004 | 164 | |
| 17 | 1995 | 134 | |
| 18 | 2005 | 132 | |
| 19 | 2011 | 126 | |
| 20 | 2005 | 115 |
About Malcolm Ranson
Malcolm Ranson is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 181 papers that have together received 11.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (47 papers), Lung Cancer Research Studies (20 papers), Cancer therapeutics and mechanisms (20 papers), Cancer Treatment and Pharmacology (18 papers), HER2/EGFR in Cancer Research (14 papers), Colorectal Cancer Treatments and Studies (13 papers), Cell death mechanisms and regulation (13 papers) and Cancer Genomics and Diagnostics (11 papers). The work is most often cited by research in Oncology (5.5k citations), Cancer Research (1.9k citations), Pulmonary and Respiratory Medicine (4.1k citations), Molecular Biology (3.7k citations) and Biomaterials (645 citations). Malcolm Ranson has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Caroline Dive, Fiona Blackhall, Andrew Hughes, Alastair Greystoke, Tim Ward, Helen Swaisland, Sarah Danson, Matthew Krebs, Glen Clack and Lynsey Priest. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, European Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.